发明名称 MODIFIED T LYMPHOCYTES
摘要 Provided herein are cells, e.g., T cells expressing artificial cell death polypeptides that cause death of a cell, e.g., cells (e.g., T lymphocytes) expressing the cell death polypeptide, when the cell death polypeptide is multimerized or dimerized. Also provided herein is use of such cells, e.g., T lymphocytes, to treat diseases such as cancer.
申请公布号 US2016030479(A1) 申请公布日期 2016.02.04
申请号 US201414775891 申请日期 2014.03.14
申请人 ANTHROGENESIS CORPORATION 发明人 Abbot Stewart;Li Tianjian;Liang Bitao
分类号 A61K35/17;A61K39/395 主分类号 A61K35/17
代理机构 代理人
主权项 1. A T lymphocyte comprising an artificial cell death polypeptide comprising an apoptosis-inducing domain, wherein said polypeptide is multimerizable using a multimerizing agent, wherein said multimerizing agent is not an FK506 binding protein (FKBP) ligand, and wherein when said multimerizing agent multimerizes said polypeptide, an apoptosis-inducing signal is generated in said T lymphocyte.
地址 Warren NJ US